ZONTIVITY is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Wraser Pharmaceuticals, Llc. The primary component is Vorapaxar Sulfate.
Product ID | 66992-208_e946b6c2-23db-0d65-e053-2a95a90acd48 |
NDC | 66992-208 |
Product Type | Human Prescription Drug |
Proprietary Name | ZONTIVITY |
Generic Name | Vorapaxar |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-09-21 |
Marketing Category | NDA / |
Application Number | NDA204886 |
Labeler Name | WraSer Pharmaceuticals, LLC |
Substance Name | VORAPAXAR SULFATE |
Active Ingredient Strength | 2 mg/1 |
Pharm Classes | Protease-activated Receptor-1 Antagonist [EPC], Protease-activated Receptor-1 Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-21 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
66992-208 | ZONTIVITY | vorapaxar |
70347-208 | ZONTIVITY | vorapaxar |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZONTIVITY 86164928 not registered Dead/Abandoned |
Merck Sharp & Dohme Corp. 2014-01-14 |
ZONTIVITY 85307417 4628973 Live/Registered |
ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY 2011-04-28 |